Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
KYNB is expected to report earnings to fall 10.90% to -334 cents per share on August 10
Q2'26
Est.
$-3.35
Q1'26
Missed
by $3.55
Q4'25
Missed
by $3.37
The last earnings report on May 11 showed earnings per share of -375 cents, missing the estimate of -20 cents. With 15.59K shares outstanding, the current market capitalization sits at 27.12M.